The use of power morcellators during a laparoscopic hysterectomy or uterine fibroid removal surgery may cause women to face an increased risk of suffering from aggressive cancers that spread throughout the uterus, pelvis and abdomen.…
A GAO report indicates that the FDA’s adverse reporting system and its voluntary nature may have delayed the agency from detecting heightened cancer risks linked to the use of power morcellators.…
The FDA has issued new guidance determining when the public should be warned about adverse events linked to medical devices already on the market.…
A new study warns that women over 50 may be more vulnerable to leiomyosarcoma cancer risks linked to the use of power morcellators.…
Olympus has received approval for a new morcellator equipped with a tissue containment bag, amid concerns that morcellators can spread cancerous cells throughout a woman’s body.…
Researchers have seen no increase in hysterectomy complications as the medical community walks back from power morcellator use over cancer fears, according to a new study.…
A federal judge is calling for the remaining few Ethicon morcellator cancer lawsuits that have not been settled to be returned to their original court districts for trial or other resolutions.…
With most Ethicon morcellator cancer lawsuits resolved, parties have asked a federal judge to dissolve the multidistrict litigation formed to handle the pretrial proceedings.…
A power morcellator lawsuit filed against LiNA Medical indicates that its XCise Laparoscopic Morcellator spread cancerous cells through a woman’s body during a hysterectomy procedure.…
The FDA has approved the first morcellation tissue containment system to collect tissue that may contain cancerous cells, but warn that the device is not proven to prevent the spread of uterine cancer through morcellation.…
